Autoantigens are self-derived molecules that become recognized by the adaptive immune system after tolerance is lost. They may be intracellular enzymes, nuclear ribonucleoproteins, membrane receptors, structural matrix proteins, microbial-response proteins, or tissue-restricted differentiation antigens. In autoimmune and immune-mediated diseases, the target profile is not simply a diagnostic label; it reflects the tissue compartment exposed to inflammation, the route of antigen presentation, the immunoglobulin class or subclass involved, and the effector mechanisms that translate autoantibody binding into tissue injury. For reagent development, assay design, and mechanistic research, each autoantigen should therefore be considered in relation to its native localization, conformational state, post-translational modification, biological function, and disease-associated epitope pattern.
Antinuclear antibodies represent a broad family of autoantibodies directed against nuclear and nucleocytoplasmic macromolecules. ANA-associated targets include chromatin components, ribonucleoprotein particles, DNA repair and transcription proteins, centromere proteins, extractable nuclear antigens, and enzymes involved in nucleic acid metabolism. These antigens are central to systemic autoimmune rheumatic diseases because they connect immune recognition with apoptotic debris, type I interferon activation, immune complex formation, complement consumption, and organ-specific injury. ANA patterns detected by HEp-2 indirect immunofluorescence often reflect the subcellular distribution of the target antigen, while solid-phase assays define individual antigen specificity.
Several recurring mechanisms explain how normally tolerated proteins become immunogenic. Cell stress, apoptosis, necrosis, degranulation, extracellular trap formation, defective clearance of immune complexes, microbial mimicry, and oxidative or enzymatic modification can all increase antigen availability. Once antigen is released or redistributed, antigen-presenting cells process peptides and activate autoreactive T cells. B cells receiving T-cell help undergo clonal expansion, affinity maturation, and class switching, producing antibodies that may serve as biomarkers, pathogenic mediators, or both. The clinical value of an autoantigen depends on antigen quality: recombinant proteins should preserve relevant epitopes, native proteins may retain conformational and post-translational features, and peptide antigens are useful when the dominant epitope is linear and well defined.
Fig. 1 Mechanisms of Immunogenicity in Antinuclear Antibodies (ANA)
The classical and commonly used targets include:
These targets should be selected according to the intended research question, assay platform, desired sensitivity and specificity, sample matrix, and whether the study requires native conformational epitopes, recombinant full-length protein, antigenic domains, or synthetic peptide epitopes.
| Target | Location | Function | Immunological Role |
| Double-stranded DNA (dsDNA) | Nucleus/chromatin | Genetic information storage and replication template | Highly associated with systemic lupus erythematosus and immune complex nephritis |
| Histones | Nucleosomes within chromatin | Package DNA and regulate chromatin accessibility | Common in drug-induced lupus and chromatin-directed lupus responses |
| Sm proteins | Small nuclear ribonucleoproteins | Pre-mRNA splicing | Highly specific marker for systemic lupus erythematosus |
| U1-RNP | Nuclear ribonucleoprotein complex | RNA splicing and snRNA-protein organization | Classical target in mixed connective tissue disease and lupus overlap |
| SSA/Ro60 and Ro52/TRIM21 | Nucleus, cytoplasm, ribonucleoprotein complexes | RNA quality control and ubiquitin-related immune regulation | Associated with Sjogren syndrome, lupus, neonatal lupus, and photosensitive disease |
| SSB/La | Nuclear ribonucleoprotein particle | RNA polymerase III transcript processing | Associated with Sjogren syndrome and ANA-positive connective tissue disease |
| Centromere proteins (CENP-A/B/C) | Centromere/kinetochore | Chromosome segregation | Associated with limited cutaneous systemic sclerosis |
| Topoisomerase I (Scl-70) | Nucleus | DNA topology regulation | Associated with diffuse systemic sclerosis and interstitial lung disease risk |
| RNA polymerase III | Nucleus | Transcription of small RNAs | Systemic sclerosis marker associated with rapidly progressive skin disease |
Anti-dsDNA antibodies are among the most disease-associated ANA specificities. Their pathogenicity is linked to immune complex deposition, complement activation, and potential cross-reactivity with renal structures.
Localization and function: Double-stranded DNA (dsDNA) is primarily associated with nucleus/chromatin. Its biological role centers on genetic information storage and replication template. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Highly associated with systemic lupus erythematosus and immune complex nephritis. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Histones become immunogenic when apoptotic chromatin is inadequately cleared. Anti-histone antibodies recognize core nucleosomal proteins and are often evaluated with chromatin or nucleosome antigens.
Localization and function: Histones is primarily associated with nucleosomes within chromatin. Its biological role centers on package dna and regulate chromatin accessibility. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Common in drug-induced lupus and chromatin-directed lupus responses. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Sm proteins are components of spliceosomal snRNP complexes. Anti-Sm antibodies are less sensitive but highly specific, making antigen purity important for assay specificity.
Localization and function: Sm proteins is primarily associated with small nuclear ribonucleoproteins. Its biological role centers on pre-mrna splicing. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Highly specific marker for systemic lupus erythematosus. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
U1-RNP autoimmunity often correlates with overlapping features such as Raynaud phenomenon, arthritis, myositis, and pulmonary involvement.
Localization and function: U1-RNP is primarily associated with nuclear ribonucleoprotein complex. Its biological role centers on rna splicing and snrna-protein organization. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Classical target in mixed connective tissue disease and lupus overlap. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Ro60 and Ro52 are distinct antigens often tested together. Ro52 is an interferon-inducible E3 ligase, while Ro60 binds small RNAs; both are important in systemic autoimmunity.
Localization and function: SSA/Ro60 and Ro52/TRIM21 is primarily associated with nucleus, cytoplasm, ribonucleoprotein complexes. Its biological role centers on rna quality control and ubiquitin-related immune regulation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Associated with Sjogren syndrome, lupus, neonatal lupus, and photosensitive disease. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
La binds nascent RNA transcripts and often appears with anti-Ro antibodies. Its clinical interpretation depends on coexisting autoantibody profile.
Localization and function: SSB/La is primarily associated with nuclear ribonucleoprotein particle. Its biological role centers on rna polymerase iii transcript processing. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Associated with Sjogren syndrome and ANA-positive connective tissue disease. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Anti-centromere antibodies generate a discrete speckled centromere ANA pattern and are linked with vascular-predominant disease phenotypes.
Localization and function: Centromere proteins (CENP-A/B/C) is primarily associated with centromere/kinetochore. Its biological role centers on chromosome segregation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Associated with limited cutaneous systemic sclerosis. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
Topoisomerase I is a nuclear enzyme that relaxes supercoiled DNA. Anti-Scl-70 antibodies are clinically important for systemic sclerosis stratification.
Localization and function: Topoisomerase I (Scl-70) is primarily associated with nucleus. Its biological role centers on dna topology regulation. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Associated with diffuse systemic sclerosis and interstitial lung disease risk. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
RNA polymerase III antibodies recognize a transcription machinery complex and illustrate how nuclear enzyme complexes become disease-defining antigenic targets.
Localization and function: RNA polymerase III is primarily associated with nucleus. Its biological role centers on transcription of small rnas. This native context is important because antibody accessibility often depends on cell activation, tissue injury, secretion, apoptosis, or extracellular deposition.
Immunological relevance: Systemic sclerosis marker associated with rapidly progressive skin disease. In research applications, this target may be used alone when a focused hypothesis is required, or combined with related antigens to resolve overlapping phenotypes, broaden analytical coverage, or compare dominant and secondary immune responses.
References
